Micellar solubilization of some poorly soluble antidiabetic drugs: A technical note

被引：90

作者：

Seedher, Neelam ^{[1
]}

Kanojia, Mamta ^{[1
]}

机构：

[1] Panjab Univ, Dept Chem, Chandigarh 160014, India

来源：

AAPS PHARMSCITECH | 2008年 / 9卷 / 02期

关键词：

antidiabetic drugs; solubility; surfactants;

D O I：

10.1208/s12249-008-9057-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：431 / 436

页数：6

共 26 条

[1] Study of the solubilization of gliclazide by aqueous micellar solutions [J].

Alkhamis, KA ;

Allaboun, H ;

Al-Moman, WY .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (04) :839-846

[2] Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy [J].

Ammar, H. O. ;

Salama, H. A. ;

Ghorab, M. ;

Mahmoud, A. A. .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 320 (1-2) :53-57

[3] Study of the inclusion of gliclazide in α-cyclodextrin [J].

Arias-Blanco, MJ ;

Moyano, JR ;

Perez-Martinez, JI ;

Gines, JM .

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (1-2) :275-279

[4]

Attwood D., 1983, SURFACTANT SYSTEMS C

[5] Saccharin as a salt former. Enhanced solubilities of saccharinates of active pharmaceutical ingredients [J].

Bhatt, PM ;

Ravindra, NV ;

Banerjee, R ;

Desiraju, GR .

CHEMICAL COMMUNICATIONS, 2005, (08) :1073-1075

[6]

CHAUCHAN C, 2005, AAPS PHARMASCITECH, V6, P50

[7]

Corvi M.P., 2003, J PHARM SCI, V92, P2177

[8] Solubility studies on valdecoxib in the presence of carriers, cosolvents, and surfactants [J].

Desai, KGH ;

Park, HJ .

DRUG DEVELOPMENT RESEARCH, 2004, 62 (01) :41-48

[9] Solubility of rofecoxib in the presence of methanol, ethanol, and sodium lauryl sulfate at (298.15, 303.15, and 308.15) K [J].

Desai, KGH ;

Kulkarni, AR ;

Aminabhavi, TM .

JOURNAL OF CHEMICAL AND ENGINEERING DATA, 2003, 48 (04) :942-945

[10] Development of a dissolution medium for glibenclamide [J].

ElMassik, MA ;

Darwish, IA ;

Hassan, EE ;

ElKhordagui, LK .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 140 (01) :69-76

← 1 2 3 →